The China Alopecia (Hair Loss) Therapeutics Market was valued at US $0.66 Bn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $1.31 Bn by 2030. The key drivers of this industry include the surge in the prevalence of Alopecia (hair loss), increased disposable income, technological advancements and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Curollax, Lutronic, Pfizer among others.
The Singapore Cold Pain Therapy Market was valued at $3 Mn in 2022 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $4 Mn by 2030. The key drivers of this industry include an upward trend in the prevalence of chronic pain disorders, rising disposable income, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Ossur, Medline, Pfizer, Hisamitsu, Johnson & Johnson, and Sanofi among others.
The UK Periodontal Therapeutics Market was valued at $22.7 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $32.4 Mn by 2030. The UK Periodontal Therapeutics Market is growing due to Rising prevalence of periodontitis, Emphasis on Preventive Oral Care, and Technological Developments. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
The Brazil Radiology Service Market was valued at $100 Mn in 2023 and is predicted to grow at a CAGR of 15.7% from 2023 to 2030, to $277.6 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Brazil Radiology Service Market are Samaritano, Sirio Libanes, Hospital Mae de Deus, Hospital Saude da Mulher, Hospital Naval Marcilio Dias, Hospital das Clínicas da Unicamp de Campinas, among others.
The Malaysia Blood Group Typing Market was valued at $5.53 Mn in 2023 and is predicted to grow at a CAGR of 9.90% from 2023 to 2030, to $10.71 Mn by 2030. The key drivers of this industry are increase in prevalence of chronic diseases, public initiatives, and rising number of surgical procedures. The key players in the industry are Grifols S.A., Roche Diagnostics, Quantum Diagnostics, and Thermo Fisher Scientific Inc.
The South Africa Cold Pain Therapy Market was valued at $14 Mn in 2022 and is predicted to grow at a CAGR of 6.43% from 2023 to 2030, to $24 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic pain disorders, supportive government initiatives, and technological advancements in the industry. The industry is primarily dominated by players such as Ossur, Rohto, Pfizer, Hisamitsu, Johnson & Johnson, Sanofi, and Breg among others.
The China Periodontal Therapeutics Market was valued at $70.2 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $125.8 Mn by 2030. China Periodontal Therapeutics Market is growing due to Economic Growth and Rising Disposable Income, Technological Advancements, and Emphasis on Preventive Oral Care. The market is primarily dominated by players such as Chartwell Pharmaceuticals LLC, ASA Dental, Steris-Hu-Friedy, Envista Holding Corporation, and Tokyo Chemical Industry Co. Ltd.
The Mexico Radiology Service Market was valued at $60 Mn in 2023 and is predicted to grow at a CAGR of 14.95% from 2023 to 2030, to $159.1 Mn by 2030. The key drivers of the market include increasing burden of cancer, aging population, and emphasis on preventative care. The prominent players of the Mexico Radiology Service Market are Hospital Guadalajara, Hospital Angeles, Hospital Americano, Hospiten International Hospital Group, and Médica Sur, among others.
The Singapore Blood Group Typing Market was valued at $4.13 Mn in 2023 and is predicted to grow at a CAGR of 10.30% from 2023 to 2030, to $8.20 Mn by 2030. The key drivers of this industry are increase in prevalence of chronic diseases, public initiatives, and rising number of surgical procedures. The key players in the industry are Grifols S.A., Parkway Laboratory Services, Raffles Medical Group, and Beckman Coulter Life Sciences.
The UAE Cold Pain Therapy Market was valued at $11 Mn in 2022 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $18 Mn by 2030. The key drivers of this industry include an upward trend in the incidence of pain disorders, technological advances in the industry, and supportive government policies. The industry is primarily dominated by players such as Julphar, Hisamitsu, Rapid Aid, Ossur, Zimmer Biomet, Breg, and Pfizer among others.
The Indonesia Periodontal Therapeutics Market was valued at $5.2 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $8.5 Mn by 2030. Indonesia Periodontal Therapeutics Market is growing due to High Prevalence of periodontitis, Emphasis on Preventive Oral Care, and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
The France Radiology Service Market was valued at $110 Mn in 2023 and is predicted to grow at a CAGR of 13.7% from 2023 to 2030, to $270.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, rising demand for non-invasive procedures, and technological advancements. The prominent players of the France Radiology Service Market are Centre Chirugical Ambroise-Pare, CHP Saint-Gregoire, Chinique de L’Alma, Centre De Radiologie Croisette, Hospital Saint Louis, and La Clinique de l'Infirmerie Protestante, among others.
The Canada Biobanks Market was valued at $6,139.20 Mn in 2023 and is predicted to grow at a CAGR of 8.80% from 2023 to 2030, to $11,079.34 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic disease, government support and funding, and advancements in medical research. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Lonza among others.
The UK Cold Pain Therapy Market was valued at $57 Mn in 2022 and is predicted to grow at a CAGR of 3.2% from 2023 to 2030, to $74 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic pain disorders, technological advances in the industry, and demand for non-invasive pain relief approaches. The industry is primarily dominated by players such as DJO Global, Breg, Beiersdorf, Ossur, Performance Health, Pfizer, and Hisamitsu among others.
The Japan Periodontal Therapeutics Market was valued at $54.2 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $91.2 Mn by 2030. Japan Periodontal Therapeutics Market is growing due to Rising Geriatric Population, Emphasis on Preventive Oral Care, and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
The Germany Radiology Service Market was valued at $146.4 Mn in 2023 and is predicted to grow at a CAGR of 12.9% from 2023 to 2030, to $342.3 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Germany Radiology Service Market are Clinic Passautraces, Helios Amper Hospital, Mittelbaden Clinic, Starnbergof Clinic, University Hospital Rechts der Isar, and University Hospital of Munich (LMU), among others.
The US Biobanks Market was valued at $32,230.80 Mn in 2023 and is predicted to grow at a CAGR of 6.80% from 2023 to 2030, to $51,082.23 Mn by 2030. The key drivers of this industry include government initiatives, growing demand for human samples, and the prevalence of chronic diseases. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
The Malaysia Periodontal Therapeutics Market was valued at $1.4 Mn in 2023 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to $2.3 Mn by 2030. Malaysia Periodontal Therapeutics Market is growing due to Rising Awareness About Dental Hygiene, High Prevalence of periodontitis and Advancements in Treatment method. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
The Spain Radiology Service Market was valued at $77.2 Mn in 2023 and is predicted to grow at a CAGR of 13.7% from 2023 to 2030, to $189.6 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, rising demand for non-invasive procedures, and aging population. The prominent players of the Spain Radiology Service Market are Centro Medico Teknon, Hospital Universitari Sagrat Cor, University Clinic of Navarra, Quirónsalud Marbella Hospital, HM Monteprincipe, and Hospital General de Catalunya, among others.
The Saudi Arabia Biobanks Market was valued at $1,304.60 Mn in 2023 and is predicted to grow at a CAGR of 10.30% from 2023 to 2030, to $2,591.20 Mn by 2030. The key drivers of this industry include advancements in research, chronic disease prevalence, and government support. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
The Vietnam Cold Pain Therapy Market was valued at $11 Mn in 2022 and is predicted to grow at a CAGR of 5.43% from 2023 to 2030, to $17 Mn by 2030. The key drivers of this industry include a surge in the prevalence of chronic pain disorders, consumer demand for non-invasive approaches, and the evolving technological landscape in the industry. The industry is primarily dominated by players such as Ossur, Rohto, Pfizer, Hisamitsu, Johnson & Johnson, Sanofi, and Breg among others.
The UK Radiology Service Market was valued at $104 Mn in 2023 and is predicted to grow at a CAGR of 12.7% from 2023 to 2030, to $240.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, rising demand for non-invasive procedures, and technological advancements. The prominent players of the UK Radiology Service Market are Chelsea and Westminister Hospital, St. Mary’s Hospital, St. George’s Hospital, The Royal London Hospital, Hammersmith Hospital, and Guy’s and St. Thomas’ Hospitals, among others.
The UAE Biobanks Market was valued at $383.70 Mn in 2023 and is predicted to grow at a CAGR of 9.80% from 2023 to 2030, to $738.26 Mn by 2030. The key drivers of this industry include personalized medicine, increasing biomedical research, and the rising prevalence of chronic disease. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
The Canada Bone Disease Therapeutics Market was valued at $1.296 Bn in 2022 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $2.563 Bn by 2030. The key drivers of this industry include the increasing aging population of Canada, improving government initiatives, technological advancements, and others. The industry is primarily dominated by players such as Roche, Pfizer, Merck, AbbVie, Novartis, Teva, and Johnson & Johnson, among others.
The Singapore Periodontal Therapeutics Market was valued at $1.1 Mn in 2023 and is predicted to grow at a CAGR of 7.8% from 2023 to 2030, to $1.8 Mn by 2030. Singapore Periodontal Therapeutics Market is growing due to Aging population, Rise in Demand for Non-surgical Periodontal Therapies, and Prevalence of periodontitis. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.